Haemonetics CORP 8-K filings

Haemonetics Corporation has finalized its acquisition of Attune Medical, a move that includes an upfront payment of $160 million and potential future payments based on sales growth and milestones.

Haemonetics Corporation has announced a definitive agreement to acquire Attune Medical for $160 million in cash upfront, plus contingent payments, to expand its presence in the electrophysiology market.

Haemonetics Corporation announced positive third quarter fiscal 2024 results, with revenue growth and increased profitability, leading to an updated fiscal year guidance.